PT-141 (Bremelanotide)

What is PT-141 (Bremelanotide)?

PT-141 is the development name widely associated with bremelanotide, a synthetic cyclic peptide and melanocortin-receptor agonist. Research literature examines its interactions with melanocortin receptors, including MC3R and MC4R, and downstream signalling pathways. This Emirates Peptides product contains 10 mg per vial and is supplied strictly as a laboratory research material.

Research Context

• Melanocortin-receptor pharmacology — receptor-binding and signalling studies
• MC3R and MC4R pathway models — mechanistic and comparative assays
• Neuroendocrine signalling — experimental pathway research
• Peptide structure and activity — cyclic-peptide characterization

Published findings from approved pharmaceutical bremelanotide must not be treated as evidence that this research-use product is an approved medicine or suitable for human use.

Product Details

• Compound: PT-141 (Bremelanotide)
• Amount: 10 mg per vial
• Format: research peptide vial
• Category: Energy & Vitality
• Price: AED 340

Quality Documentation

Review batch-specific analytical documentation when available. This page does not imply that a Certificate of Analysis, sterility result, mass-spectrometry result, or batch-specific purity certificate exists unless that exact document has been uploaded and verified.

Research-Use Disclaimer

For laboratory research and development only. Not for human or veterinary use, administration, diagnosis, treatment, prevention, food, cosmetic, or household use. It is not sold as a drug, supplement, or medical device.